Andrew Craig Miller
CIK: 0001777760
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Miller Andrew Craig
Miller Andrew Craig (SEC CIK 0001777760) files insider reports with the SEC as Director of Alto Neuroscience, Inc. (ANRO) and Director of Kyverna Therapeutics, Inc. (KYTX).
Signal8 holds 4 ownership filings by Miller Andrew Craig (2 Form 3, 2 Form 4), filed between Mar 4, 2026 and May 29, 2026. Those filings report 2 transactions, from Feb 24, 2026 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Miller Andrew Craig's filings is in EMERYVILLE, CA.
Recent filings by Miller Andrew Craig
Other insiders filing for Alto Neuroscience, Inc. (ANRO)
- Smith Nicholas Conrad, PRESIDENT AND CFO
- Etkin Amit, PRESIDENT AND CEO
- Sanchez Ramiro, Director
- Cox Christopher Nixon, Director
- Manji Husseini, Director
- Dreyfus Andrew, Director